Anxiety induced by simulated public speaking and stroop color word test in healthy subjects: effects of different trait-anxiety levels.

A W Zuardi , S M Palma , Francisco Silveira Guimarães
Brazilian Journal of Medical and Biological Research 27 ( 12) 2895 -2902

27
1994
Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.

A W Zuardi , I G Karniol
Brazilian Journal of Medical and Biological Research 16 ( 2) 141 -146

31
1983
Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.

I C Karniol , N A Teixeira , A W Zuardi
Archives internationales de pharmacodynamie et de thérapie 269 ( 1) 12 -19

29
1984
Chemical composition of Brazilian marihuana samples and the importance of several constituents to the pharmacological activity of the plant

I G Karniol , A W Zuardi , R N Takahashi
Revista brasileira de pesquisas medicas e biologicas 10 ( 6) 379 -385

2
1977
Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers.

A W Zuardi , F S Guimarães , A C Moreira
Brazilian Journal of Medical and Biological Research 26 ( 2) 213 -217

60
1993
Ipsapirone reduces increases in anxiety during a simulated public speaking test

A W Zuardi , Frederico Guilherme Graeff , R A Cosme , Francisco Silveira Guimarães
Journal of Psychopharmacology 4 296

3
1990
Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.

Finkelfarb E , Karniol Ig , Bueno Of , Musty Re
Archives internationales de pharmacodynamie et de thérapie 249 ( 1) 137 -146

29
1981
[A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].

Oliveira Ma , Giampietro Ac , Karniol Ig , Zuardi Aw
Acta psiquiatrica y psicologica de America latina 29 ( 4) 261

1
1983
2021
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers

R. Martin-Santos , J. A. Crippa , A. Batalla , S. Bhattacharyya
Current Pharmaceutical Design 18 ( 32) 4966 -4979

256
2012
Cannabidiol was ineffective for manic episode of bipolar affective disorder.

AW Zuardi , JAS Crippa , SM Dursun , SL Morais
Journal of Psychopharmacology 24 ( 1) 135 -137

50
2010
Cannabidiol for the treatment of psychosis in Parkinson’s disease

AW Zuardi , Jas Crippa , JEC Hallak , JP Pinto
Journal of Psychopharmacology 23 ( 8) 979 -983

191
2009
www. expert-reviews. com 1217

MB Aerts , S Ankolekar , DM Araujo , P Bansil

The effect of cannabidiol (CBD), a cannabis sativa constituent, on neural correlates of anxiety: a regional cerebral blood flow study

Jose Alexandre Crippa , G Derenusson , AW Zuardi , L Wichert-Ana
Schizophrenia Bulletin 35 197 -198

4
2009
WFN15-1186 Epilepsy Neuroprotective effects of Cannabidiol in the acute pilocarpine model of temporal lobe seizure in rats

RA DoVal-da Silva , JB De Ross , RC Scandiuzzi , I Esteves
Abstracts/Journal of the Neurological Sciences 357 e142 -e160

2015
Performance of schizophrenic patients in the Stroop Color Word Test after a single dose of cannabidiol

JEC Hallak , JAS Crippa , RF Sanches , DC Bosi
JOURNAL OF PSYCHOPHARMACOLOGY 16 ( 3) A15 -A15

2002
Effects of cannabidiol on (s)-ketamine-induced psychopathology in healthy volunteers.

DC Bosi , JEC Hallak , SM Dursun , JFW Deakin
Journal of Psychopharmacology 17 ( 3) A55 -A55

24
2003